“Laboratory Assessment of Liver Function in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil”. Research, Society and Development 11, no. 13 (September 28, 2022): e74111335082. Accessed December 5, 2025. https://rsdjournal.org/rsd/article/view/35082.